| dc.contributor.author | Boucher, C. A. B. | |
| dc.contributor.author | Tabak, F. | |
| dc.contributor.author | van Vuuren, A. J. | |
| dc.contributor.author | ter Borg, M. J. | |
| dc.contributor.author | Janssen, H. L. A. | |
| dc.contributor.author | Rijckborst, V. | |
| dc.contributor.author | Hansenu, B. E. | |
| dc.contributor.author | Cakaloglu, Y. | |
| dc.contributor.author | Ferenci, P. | |
| dc.contributor.author | Akdogan, M. | |
| dc.contributor.author | Simon, K. | |
| dc.contributor.author | Akarca, U. S. | |
| dc.contributor.author | Flisiak, R. | |
| dc.contributor.author | Verhey, E. | |
| dc.date.accessioned | 2021-03-04T12:51:04Z | |
| dc.date.available | 2021-03-04T12:51:04Z | |
| dc.identifier.citation | Rijckborst V., Hansenu B. E. , Cakaloglu Y., Ferenci P., Tabak F., Akdogan M., Simon K., Akarca U. S. , Flisiak R., Verhey E., et al., "EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS", 45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 14 - 18 Nisan 2010, cilt.52 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_796d799c-6178-4fda-9320-f8adeada954c | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/83228 | |
| dc.identifier.uri | https://doi.org/10.1016/s0168-8278(10)60010-4 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS | |
| dc.type | Bildiri | |
| dc.contributor.department | Erasmus University Rotterdam , , | |
| dc.identifier.volume | 52 | |
| dc.contributor.firstauthorID | 136864 | |
